TWi Biotechnology (ROCO:6610) Total Stockholders Equity : NT$175.85 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is TWi Biotechnology Total Stockholders Equity?

TWi Biotechnology's Total Stockholders Equity for the quarter that ended in Dec. 2024 was NT$175.85 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. TWi Biotechnology's Book Value per Share for the quarter that ended in Dec. 2024 was NT$1.91. The ratio of a company's debt over equity can be used to measure how leveraged this company is. TWi Biotechnology's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.09.

TWi Biotechnology Total Stockholders Equity Historical Data

The historical data trend for TWi Biotechnology's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TWi Biotechnology Total Stockholders Equity Chart

TWi Biotechnology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

294.11

278.80

205.92

341.04

175.85

TWi Biotechnology Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial															205.92	165.25	341.04	243.65	175.85

TWi Biotechnology (ROCO:6610) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

TWi Biotechnology's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(175.847	-	0)	/	92.196
	=	1.91

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

TWi Biotechnology's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(12.657	+	2.946)	/	175.847
	=	0.09

TWi Biotechnology Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of TWi Biotechnology's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

TWi Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TWi Biotechnology Inc (ROCO:6610) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 221, Kang Chien Road, 8th Floor, Number 41, Neihu District, Taipei, TWN, 11494

Website

https://www.twibiotech.com

TWi Biotechnology Inc is a clinical-stage biopharmaceutical company based in Taiwan. It is engaged in the development of new drugs for unmet medical needs, particularly in the diseases associated with innate immunity. The pipeline products of the company comprise AC-201, AC-203, and AC-701.

TWi Biotechnology Headlines

No Headlines